Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Alessia Volpe"'
Autor:
Elena Skourti, Alessia Volpe, Cameron Lang, Preeth Johnson, Fani Panagaki, Gilbert O. Fruhwirth
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMicroRNAs are small non-coding RNAs and represent key players in physiology and disease. Aberrant microRNA expression is central to the development and progression of cancer, with various microRNAs proposed as potential cancer biomarkers
Externí odkaz:
https://doaj.org/article/c05f89262dde4d91a54cefcbc020765c
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Cellular immunotherapies have emerged as a successful therapeutic approach to fight a wide range of human diseases, including cancer. However, responses are limited to few patients and tumor types. An in-depth understanding of the complexity and dyna
Externí odkaz:
https://doaj.org/article/3255496848514f59a5af9c0b5b90d333
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 447-458 (2021)
Several types of gene- and cell-based therapeutics are now emerging in the cancer immunotherapy, transplantation, and regenerative medicine landscapes. Radionuclear-based imaging can be used as a molecular imaging tool for repetitive and non-invasive
Externí odkaz:
https://doaj.org/article/b17ef43a05554527b97d4ce690ab9e5f
Autor:
Jacinta Jacob, Suchita Nadkarni, Alessia Volpe, Qi Peng, Sim L. Tung, Rosalind F. Hannen, Yasmin R. Mohseni, Cristiano Scotta, Federica M. Marelli-Berg, Robert I. Lechler, Lesley A. Smyth, Gilbert O. Fruhwirth, Giovanna Lombardi
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 324-336 (2021)
Regulatory T cells (Tregs) are emerging as a new cell-based therapy in solid organ transplantation. Adoptive transfer of Tregs has been shown preclinically to protect from graft rejection, and the safety of Treg therapy has been demonstrated in clini
Externí odkaz:
https://doaj.org/article/dcb780cc658b4eca9c8ec6f37d4a09f0
Autor:
Jacinta Jacob, Alessia Volpe, Qi Peng, Robert I. Lechler, Lesley A. Smyth, Giovanna Lombardi, Gilbert O. Fruhwirth
Publikováno v:
Molecules, Vol 28, Iss 3, p 1482 (2023)
Regulatory T cells (Tregs) are a promising candidate cell therapy to treat autoimmune diseases and aid the longevity of transplanted solid organs. Despite increasing numbers of clinical trials using human Treg therapy, important questions pertaining
Externí odkaz:
https://doaj.org/article/c2ce8a9f7b0347a791e20018dcb780c4
Autor:
Ines M. Costa, Noor Siksek, Alessia Volpe, Francis Man, Katarzyna M. Osytek, Elise Verger, Giuseppe Schettino, Gilbert O. Fruhwirth, Samantha Y. A. Terry
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 24, p 13466 (2021)
Auger electron-emitters increasingly attract attention as potential radionuclides for molecular radionuclide therapy in oncology. The radionuclide technetium-99m is widely used for imaging; however, its potential as a therapeutic radionuclide has not
Externí odkaz:
https://doaj.org/article/11d5eae5bf084bd6b24dd3daa41f5cc2
Autor:
Johanna Pruller, Truc Thuy Pham, Julia E. Blower, Putthiporn Charoenphun, Alessia Volpe, Kavitha Sunassee, Gregory E. D. Mullen, Philip J. Blower, Richard A. G. Smith, Michelle T. Ma
Publikováno v:
RSC Chemical Biology. 4:65-73
An indium-111-labelled peptide binds to myeloma cells, enabling SPECT imaging of myeloma cell accumulation in lungs after intravenous administration. This is the first report of a radiolabelled cell-membrane binding peptide for cell tracking.
Publikováno v:
NK Cells in Cancer Immunotherapy: Successes and Challenges ISBN: 9780128226209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33e220ae1f0097ea72be30267b323749
https://doi.org/10.1016/b978-0-12-822620-9.00008-2
https://doi.org/10.1016/b978-0-12-822620-9.00008-2
Autor:
Maria M. Abreu, Prasad S. Adusumilli, Behnam Badie, Rafet Basar, Rebecca Bellis, Ronald Blasberg, Barbara Breznik, Shyambabu Chaurasiya, Po-Chun Chen, Kevin Choong, Nishant Chovatiya, May Daher, Supriya Deshpande, Lisa Feldman, Timothy D. Folsom, Christina Fong, Yuman Fong, Jacqueline Gouvea, Anamarija Habič, Anahid Jewett, Sharyn I. Katz, Kawaljit Kaur, Meng-Wei Ko, Janko Kos, Derek Lee, Zhe Li, Emil Lou, Dipnarine Maharaj, Kelly Mahuron, Bernarda Majc, Sandro Matosevic, Branden S. Moriarity, John P. Murad, Ishwar Navin, Metka Novak, Robin Parihar, Anthony K. Park, Vineet Polineni, Vladimir Ponomarev, Saul J. Priceman, Hind Rafei, Jamie Rand, Katayoun Rezvani, Isabelle Rivière, Leonid Roshkovan, Saeed Sadeghi, Jasmeen Saini, Emanuela Senjor, Inna Serganova, Timothy K. Starr, Tamara Lah Turnsek, Alessia Volpe, Xiuyan Wang, Beau R. Webber, Paul Wong, Yanghee Woo, Jennifer Wu, Lili Yang, Yuan Yuan, Samuel Zeng, Amy Zhu
Publikováno v:
NK Cells in Cancer Immunotherapy: Successes and Challenges ISBN: 9780128226209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05036980bcfb2beeb32a5ae9f0c849aa
https://doi.org/10.1016/b978-0-12-822620-9.09986-9
https://doi.org/10.1016/b978-0-12-822620-9.09986-9
Autor:
Yasmin R. Mohseni, Amy Cross, Gilbert O. Fruhwirth, Qi Peng, Sim L. Tung, Robert I. Lechler, Cameron Lang, Cristiano Scottà, Joanna Hester, George Adigbli, Fadi Issa, Alessia Volpe, Caroline Dudreuilh, Farzin Farzaneh, Giovanna Lombardi, Adeel Saleem
Publikováno v:
European Journal of Immunology
Clinical trials of Treg therapy in transplantation are currently entering phases IIa and IIb, with the majority of these employing polyclonal Treg populations that harbor a broad specificity. Enhancing Treg specificity is possible with the use of chi